Bio Elpida, facilities dedicated to Active Therapeutic Medicinal Product
120 m² devoted to the production and quality control of ATMP clinical batches

Bio Elpida has a Pharmaceutical zone dedicated and certified for the production of Advanced Therapeutic Medicinal Product (ATMP) such as:
  • Autologous and Allogenic cancer-vaccine
  • Allogenic cancer-vaccine
  • Immuno-therapy
  • Regenerative medicine

Our experienced staff has already manufactured clinical batches of ATMP for early and late stage clinical trials. These clinical batches have been produced for both US and EU studies for autologous and allogenic applications.

Bio Elpida

Founded in 2009, Bio Elpida is a Biotechnology Contract Development and Manufacturing Company specialised in the development and manufacturing of innovative cell therapies.

The expertise of the company covers 3 areas:
In these areas, Bio Elpida offers services that include:
Bio Elpida is the first French laboratory certified by the French Health Authorities (MSNA) as a Pharmaceutical Company and authorised to manufacture Active Pharmaceutical Ingredients for experimental biological pharmaceuticals.
Expertise
Services
R&D and Feasibility
Pharmaceutical Development
Single-Use Approach
Optimisation & Scale up
Analytical Method
Manufacturing and Control
Testing
Aseptic Fill & Finish
Support
Formulation
Regulation IMPD
Drug Analytical Development
Bulk Purification


Facilities
R&D Facilities
Feasibility Facilities
API Facilities
ATMP Facilities

Team


Company

News

Contact
Bio Elpida - 97 allée Alexandre Borodine - Bâtiment 5 Cèdre 1 - 69800 Saint Priest - FRANCE - Phone: +33 (0)4 78 47 02 70 - Mail: infos@bio-elpida.com
© Bio Elpida. All Rights Reserved - Legal information - Web site by: Estium-Concept
  • Your CDMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  • Your CDMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  • Your CDMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  •  
  •  
  •